AQR Capital Management Portfolio holdings
AUM
$121B
1-Year Return
23.38%
This Quarter Return
-3.05%
1 Year Return
+23.38%
3 Year Return
+85.44%
5 Year Return
+156.19%
10 Year Return
+370.97%
AUM
$52.7B
AUM Growth
-$2.48B
(-4.5%)
Cap. Flow
-$56.4M
Cap. Flow
% of AUM
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
2,375
New
187
Increased
1,008
Reduced
966
Closed
158
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$211M |
| 2 |
Pfizer
PFE
|
$200M |
| 3 |
Moderna
MRNA
|
$146M |
| 4 |
Gilead Sciences
GILD
|
$88.1M |
| 5 |
EPAM Systems
EPAM
|
$79.9M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$139M |
| 2 |
Target
TGT
|
$135M |
| 3 |
Costco
COST
|
$122M |
| 4 |
AngloGold Ashanti
AU
|
$122M |
| 5 |
Microsoft
MSFT
|
$114M |
Sector Composition
| 1 | Technology | 22.97% |
| 2 | Healthcare | 15.7% |
| 3 | Industrials | 11.73% |
| 4 | Financials | 11.69% |
| 5 | Consumer Discretionary | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Oramed Pharmaceuticals
ORMP
$91.4M
| $155K | ﹤0.01% |
17,954
-2,021
| -10% | -$17.4K |
|
2102
First Bank
FRBA
$421M
| $152K | ﹤0.01% |
10,687
-1,342
| -11% | -$19.1K |
|
2103
Veru
VERU
$49.4M
| $149K | ﹤0.01% |
3,095
+724
| +31% | +$34.9K |
|
2104
NeoGenomics
NEO
$1.03B
| $147K | ﹤0.01% |
12,098
-1,562
| -11% | -$19K |
|
|
HT
2105
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $147K | ﹤0.01% |
+16,234
| New | +$147K |
|
2106
MannKind Corp
MNKD
$1.7B
| $145K | ﹤0.01% |
39,517
-9,760
| -20% | -$35.8K |
|
2107
Humacyte
HUMA
$226M
| $143K | ﹤0.01% |
+20,279
| New | +$143K |
|
|
CMRX
2108
DELISTED
Chimerix, Inc.
CMRX
| $143K | ﹤0.01% |
31,181
-28,914
| -48% | -$133K |
|
2109
Ocular Therapeutix
OCUL
$2.37B
| $141K | ﹤0.01% |
28,395
+6,675
| +31% | +$33.1K |
|
2110
Lifetime Brands
LCUT
$97.2M
| $139K | ﹤0.01% |
10,801
-3,527
| -25% | -$45.4K |
|
|
KG
2111
Kestrel Group, Ltd.
KG
$200M
| $139K | ﹤0.01% |
2,893
-219
| -7% | -$10.5K |
|
2112
Globalstar
GSAT
$3.96B
| $137K | ﹤0.01% |
6,228
-9,766
| -61% | -$215K |
|
2113
Evolus
EOLS
$495M
| $136K | ﹤0.01% |
12,145
-115,608
| -90% | -$1.29M |
|
|
INN
2114
Summit Hotel Properties
INN
$614M
| $135K | ﹤0.01% |
+13,546
| New | +$135K |
|
2115
Rush Street Interactive
RSI
$2.02B
| $134K | ﹤0.01% |
+18,437
| New | +$134K |
|
2116
Aemetis
AMTX
$151M
| $133K | ﹤0.01% |
10,496
-3,954
| -27% | -$50.1K |
|
2117
Akebia Therapeutics
AKBA
$785M
| $132K | ﹤0.01% |
184,465
+102,691
| +126% | +$73.5K |
|
2118
Viking Therapeutics
VKTX
$3.03B
| $132K | ﹤0.01% |
+43,925
| New | +$132K |
|
2119
Alto Ingredients
ALTO
$90.6M
| $129K | ﹤0.01% |
+18,918
| New | +$129K |
|
|
HARP
2120
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $126K | ﹤0.01% |
2,533
-416
| -14% | -$20.7K |
|
2121
Opendoor
OPEN
$4.89B
| $124K | ﹤0.01% |
+14,376
| New | +$124K |
|
2122
Q32 Bio
QTTB
$20.4M
| $123K | ﹤0.01% |
+2,243
| New | +$123K |
|
|
AMTI
2123
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $119K | ﹤0.01% |
+15,853
| New | +$119K |
|
2124
FuelCell Energy
FCEL
$92.3M
| $118K | ﹤0.01% |
685
-2,971
| -81% | -$512K |
|
2125
Mistras Group
MG
$307M
| $118K | ﹤0.01% |
17,903
-3,801
| -18% | -$25.1K |
|